ArticleAging2021

Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment.

Taciane Barbosa Henriques et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.